EXTON, Pennsylvania
,
April 4, 2022
(press release)
–
West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced its participation at the 2022 PDA Annual meeting to include sharing the latest in packaging science with scientific talks, moderating session panels and presenting posters, throughout the meeting. "With ever evolving patient needs and changing healthcare landscape, West remains on the forefront of packaging science by helping our customers address new demands and needs," said Cindy Reiss-Clark, Senior Vice President, Global Market Units and Commercial Solutions at West. "Through these presentations, posters and panels at the 2022 PDA Annual Meeting, we are sharing the cutting edge of packaging technology and knowledge that helps our customers speed their development of important therapies and drive better patient outcomes." Featured Speaking Sessions: Featured Poster Sessions: Title: Understanding the interactions of prefilled syringes with therapeutic proteins at low concentrations Title: Utilizing Interfacial Tension to Reduce Prefilled Syringe Functionality Risks Moderated Panels: Session: Interest Group, IG5: Packaging Science Session: Manufacturing Science For more information about West, please visit our website: www.westpharma.com. For more information about the 2022 PDA Annual Meeting, please visit: https://www.pda.org/global-event-calendar/event-detail/2022-pda-annual-meeting. About West Headquartered in Exton, Pennsylvania, and in business for nearly a century, West in its fiscal year 2021 generated $2.83 billion in net sales. West is traded on the New York Stock Exchange (NYSE: WST) and is included on the Standard & Poor's 500 index. For more information, visit www.westpharma.com. All trademarks and registered trademarks used in this release are the property of West Pharmaceutical Services, Inc. or its subsidiaries, in the United States and other jurisdictions, unless otherwise noted. SOURCE West Pharmaceutical Services, Inc. Primary Media Contact: Cynthia Salitsky, Director, External Global Communications, +1-484-983-4893, Cynthia.Salitsky@westpharma.com; Secondary Media Contact: Michele Polinsky, Vice President, Global Communications, +1-610-594-3054, Michele.Polinsky@westpharma.com
Title: Development of a Closed-Loop Wearable Injector System for Emergency Delivery of Naloxone
Speaker: Alexander Lyness, Ph.D., Senior Manager, Research & Technology
Session: Manufacturing Science, C3: Responding to Patient Needs
Date and time: April 6 at 10:45 a.m. CDT
Title: Experimental and Theoretical Evaluation of Vial Container Closure System Components Using the DeltaCube™ Modeling Platform
Author: Anthony Bucci, Principal Research Engineer
Authors: Leo Breydo, Senior Scientist
Author: Liang Fang, Technical Director/Fellow Scientist and Marissa Rase, Associate Scientist
Session: Enter Player 2
Speaker: Diane Paskiet, Director, Scientific Affairs
Date and time: April 4 at 3:30 p.m. CDT
Speaker: Susan Dounce, Ph.D., Director of Commercial Technology Development
Date and time: April 6 at 8:30 a.m. CDT
Speaker: Diane Paskiet, Director, Scientific Affairs
Date and time: April 6 at 10:45 a.m. CDT
West Pharmaceutical Services, Inc. is a leading provider of innovative, high-quality injectable solutions and services. As a trusted partner to established and emerging drug developers, West helps ensure the safe, effective containment and delivery of life-saving and life-enhancing medicines for patients. With approximately 10,000 team members across 50 sites worldwide, West helps support our customers by delivering over 45 billion components and devices each year.
* All content is copyrighted by Industry Intelligence, or the original respective author or source. You may not recirculate, redistrubte or publish the analysis and presentation included in the service without Industry Intelligence's prior written consent. Please review our terms of use.
